October 1, 2024:
The Big Ten Cancer Research Consortium (Big Ten CRC) congratulates Kari Wisinski, MD, on receiving the 2024 Pat Loehrer Award for Exemplary Collaboration in Cancer Research.
- Home
- About Us
- News & Events
- Leadership
- Raymond J. Hohl, MD, PhD
- Raphael E. Pollock, MD, PhD
- Monika Joshi, MD, MRCP
- Oana Danciu, MD
- Timothy Fan, PhD, DVM
- Nabil Adra, MD
- Muhammad Furqan, MD
- Vu Hong Duong, MD, MS
- Aki Morikawa, MD, PhD
- Daniel Isaac, DO
- Veronika Bachanova, MD, PhD
- Vijaya Raj Bhatt, MBBS, MS
- Jyoti Patel, MD
- John L. Hays, MD, PhD
- Patrick C. Ma, MD, MSc
- Thomas G. Sors, PhD
- Salma Jabbour, MD
- Kari Wisinski, MD
- Member Institutions
- University of Illinois Cancer Center
- The Cancer Center at Illinois
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
- Holden Comprehensive Cancer Center, University of Iowa
- The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
- University of Michigan Rogel Cancer Center
- Michigan State University Cancer Research
- Masonic Cancer Center, University of Minnesota
- Fred & Pamela Buffett Cancer Center (University of Nebraska)
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Penn State Cancer Institute
- Purdue University Institute for Cancer Research
- Rutgers Cancer Institute of New Jersey
- University of Wisconsin Carbone Cancer Center
- Clinical Research
- Current Trials
- Research Criteria
- Diversity Resources
- Adolescent and Young Adult Clinical Trial Working Group
- Basket Trial Clinical Trial Working Group
- Bone Marrow / Stem Cell Transplant Clinical Trial Working Group
- Breast Cancer Clinical Trial Working Group
- Comparative Oncology Clinical Trial Working Group
- Correlative Sciences Clinical Trial Working Group
- Gastrointestinal Clinical Trial Working Group
- Genitourinary Clinical Trial Working Group
- Gynecologic Clinical Trial Working Group
- Head and Neck Clinical Trial Working Group
- Lymphoid Malignancies Clinical Trial Working Group
- Melanoma/Cutaneous Oncology Clinical Trial Working Group
- Multiple Myeloma Clinical Trial Working Group
- Myeloid Malignancies Clinical Trial Working Group
- Neuro-Oncology Clinical Trial Working Group
- Population Science Clinical Trial Working Group
- Sarcoma Clinical Trial Working Group
- Thoracic Clinical Trial Working Group
- Donate
- Contact
News & Developments
Big Ten CRC gastric, gastroesophageal study published in The Oncologist
October 10, 2024: A Big Ten Cancer Research Consortium (Big Ten CRC) study, BTCRC-GI15-015, led by Al B. Benson III, MD, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, was published in The Oncologist on September 18, 2024. The article is titled, “A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial.” Congratulations to all co-authors and study teams whose hard work led to this publication. Read More
Release of RFA for 2025 Kenneth and Verna Mae Jessen Award
October 1, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) is pleased to announce the release of a Request for Applications (RFA) for its 2025 Kenneth and Verna Mae Jessen Award. This award will provide $65,000 in funding. It is expected that 100% of the award will support direct research costs. The Big Ten CRC Foundation will provide up to 10% overhead (F&A) from other funding sources. The Big Ten CRC Foundation established the Kenneth and Verna Mae Jessen Award to support basic, correlative, clinical, or population science oncology research based at a Big Ten CRC institution. The award is made possible through the generous support of the Verna Mae Jessen Trust. The Jessen family’s passion for oncology research stems from their long history with cancer. Several members of the family, including...
BTCRC-LUN17-127 published in Lung Cancer Journal
September 4, 2024: A Big Ten Cancer Research Consortium (Big Ten CRC) study manuscript was published in Lung Cancer Journal on August 15, 2024. The article is titled, “Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study.” Congratulations to all co-authors and study teams whose hard work led to this publication. Read More
Big Ten CRC 2023-24 Manuscripts & Meeting Abstracts
August 12, 2024: The Big Ten Cancer Research Consortium is happy to celebrate the research accomplishments of our members over the past year. Congratulations to all researchers and study teams whose hard work produced eight journal manuscripts and meeting abstracts between July 1, 2023, and June 30, 2024! Read More
Big Ten Cancer Research Consortium Set to Grow as Conference Expands
August 2, 2024: The expansion of the Big Ten Conference on August 2 to include four new members creates an opportunity for growth of the Big Ten Cancer Research Consortium (Big Ten CRC). The Big Ten CRC has invited the new members of the athletic conference – the University of California at Los Angeles, the University of Oregon, the University of Southern California, and the University of Washington – to join the Big Ten CRC. Plans to expand the Big Ten CRC are proceeding. Read More
Isaac represents Michigan State University on Big Ten CRC Steering Committee
July 24, 2024: Daniel Isaac, DO, an Assistant Professor in the Division of Hematology and Oncology at Michigan State University College of Human Medicine, has been appointed to represent Michigan State University on the Big Ten Cancer Research Consortium Steering Committee. Read More
Population Science Working Group Receives $5,000 for Rural Cancer Survivorship Research
July 23, 2024: The Big Ten Cancer Research Consortium (Big Ten CRC) Population Science Clinical Trial Working Group has received $5,000 of a $90,000 donation to be used for collaborative research regarding rural cancer survivorship. The donation is the second given to the Big Ten CRC by the Verna Mae Jessen Trust, with the first donation of $100,000 given in 2022. Read More
Big Ten CRC Releases Two New Podcast Episodes
July 15, 2024: The Big Ten Cancer Research Consortium has launched new episodes for each of our podcast series: "Bridging the Gap" and "AYA Cancer in Focus." Read More
Dr. Mark Burkard named director of Holden Comprehensive Cancer Center
July 12, 2024: Mark Burkard, MD, PhD, has been named director of Holden Comprehensive Cancer Center at the University of Iowa, and will begin his new role on October 1, pending approval from the Iowa Board of Regents. He will also begin as professor in the Department of Internal Medicine in the Division of Hematology, Oncology, and Blood Marrow Transplantation in the Carver College of Medicine. Read More
Illinois
University of Illinois
Indiana
Indiana University
Iowa
University of Iowa
Maryland
University of Maryland
Michigan
University of Michigan
Michigan State
Michigan State
Minnesota
University of Minnesota
Nebraska
University of Nebraska
Northwestern
Northwestern University
Ohio State
Penn State
Penn State University
Purdue
Purdue University
Rutgers
Rutgers State University
Wisconsin
University of Wisconsin
UIC
University of Illinois at Chicago
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube